CFSRE Staff’s AAFS Workshops, Presentations, and Posters
Poster
Tuesday| Time | Platform Number | Title | Speaker |
|---|---|---|---|
| 5:00-6:30PM | N/A | Tracking and Disseminating Data on Novel Psychoactive Substances (NPS) through NPS Discovery’s Drug Early Warning System |  Alex Krotulski, PhD  Sara Walton, MS |
Friday
| Time | Platform Number | Title | Speaker |
|---|---|---|---|
| 11:30AM-1:00PM | Y29 (Toxicology) | The Evaluation of Novel Psychoactive Substance Drug Loss From Storage in Serum Separator Tubes |  Devin Kress, BS |
Workshops
Tuesday| Time | Platform Number | Title | Speakers |
|---|---|---|---|
| W26 | Taming the Wild West of Workflows for Opioids: Emerging and Controversial Drug Threats |  Michael F Rieders, Session Co-Chair |
|
| 1:40-2:05PM | W26 | Taking the Lab into the Field—Challenges and Tradeoffs for the Point of Use Testing |  Barry Logan, PhD |
| 4:15-4:45PM | W26 | Legal Questions Arising from Changes to Forensic Workflows Involving New Technologies |  MJ Menendez, JD |
Presentations
Tuesday| Time | Platform Number | Title | Speaker |
|---|---|---|---|
| 1:50-2:15PM | N/A | Assessment of the Contribution to Drug-Impaired Driving from Emerging and Undertested Drugs |  Mandi Mohr, MSFS |
Thursday
| Time | Platform Number | Title | Speaker |
|---|---|---|---|
| 10:00-10:45AM | L41 | The Continually Expanding World of Designer Benzodiazepines |  Donna Papsun, MS |
| 1:00-1:15PM | L46 |
An Unusual Case of Misrepresented Cocaine Powder That Resulted in Fatal and Non-Fatal Intoxications Involving the Novel Synthetic Opioid Etodesnitazene |
Alex Krotulski, PhD |
| 1:45-2:00PM | L49 | Adverse Effects of Veterinary Pharmaceuticals as Toxic Adulterating Agents in Illicit Drug Deaths | Barry Logan, PhD |
| 4:15-4:30PM | B85 | The Development and Validation of a Quantitative Method for the Analysis of Fentanyl Containing “Dope” Samples |  Joshua DeBord, PhD |
| 4:30-5:00PM | G13 | The Academy Standards Board (ASB) Standard Compliant Toxicology Report Content as a Tool to Support Informed Pre-Charging Communication and Testimony Planning | MJ Menendez, JD |
| 5:00-5:15PM | B88 | The Development and Validation of a Method for the Differentiation of Hemp and Marijuana by Gas Chromatography/Mass Spectrometry (GC/MS) |  Sarah Shuda, MSFS |
Friday
| Time | Platform Number | Title | Speaker |
|---|---|---|---|
| 9:30-9:45AM | L58 | Impaired Driving Drug Trends and Stop Limit Testing Evaluation |  Grace Cieri, MSFT |
| 10:00-10:15AM | B157 |
The Conversion of Cannabidiol to Delta-9-Tetrahydrocannabinol (delta-9-THC) During Gas Chromatography/Mass Spectrometry (GC/MS) Analysis |
Sarah Shuda, MSFS |
| 10:30-10:45AM | B159 | The Evaluation of Fentanyl and Fentanyl-Related Compounds on United States Paper Currency |  Matthew Hewes, MS |
| 11:30-11:45AM | L65 | Toxicological Surveillance of Clinical Patients Presenting to the Emergency Department After Suspected Opioid Overdoses: Geographical Trends and Impacts on Forensic Toxicology FSF Emerging Forensic Scientist Award Oral Presentation |
Sara Walton, MS |
| 2:30-2:45PM | B142 | An investigation of Forensic Applications for Nanoplate-Based Digital Polymerase Chain Reaction (PCR) |  Mirna Ghemrawi, PhD |
